TAKEDA PHARM.CO.LTD./ JP3463000004 /

9/29/2023 9:16:58 AM	Chg. +0.1700	Volume	Bid5:38:46 PM	Ask5:35:39 PM	Market Capitalization	Dividend Y.	P/E Ratio
29.3600EUR	+0.58%	0 Turnover: 0.0000	28.8000Bid Size: 1,000	29.4000Ask Size: 1,000	46.26 bill.EUR	-	-

TeleTrader 9/1/2021 No proof deaths related to Moderna shot - Takeda

TeleTrader 8/24/2020 Takeda sells its consumer healthcare unit to Blackstone

TeleTrader 8/7/2020 Novavax, Takeda partner on COVID vaccine in Japan

TeleTrader 5/9/2019 Novartis to buy eye drug from Takeda for $3.4B

TeleTrader 1/8/2019 S&P cuts Takeda's rating, upgrades Shire

TeleTrader 1/8/2019 Takeda completes $62B Shire acquisition

TeleTrader 12/5/2018 Takeda shareholders approve Shire acquisition

TeleTrader 11/20/2018 EU conditionally approves Takeda-Shire merger

TeleTrader 11/12/2018 Takeda to vote on $62B Shire deal next month

TeleTrader 10/18/2018 Japan regulator approves Takeda's acquisition of Shire

TeleTrader 9/14/2018 Takeda secures China's green light for buying Shire

TeleTrader 7/10/2018 US regulator approves Takeda-Shire deal

TeleTrader 6/28/2018 Takeda votes against need for advanced approval of Shire deal

TeleTrader 5/8/2018 Takeda to take over Shire for £46B in cash, stock

TeleTrader 4/20/2018 Shire notes Takeda offers ownership of 49%

TeleTrader 4/20/2018 Takeda raises offer for Shire to £43B

TeleTrader 4/19/2018 Japan's Takeda offers £42.4B for drugmaker Shire

TeleTrader 3/28/2018 Shire: No takeover offer was made by Takeda

TeleTrader 1/5/2018 Takeda to acquire biotech firm TiGenix

TeleTrader 12/15/2016 Fujifilm snaps up Takeda's pharma research branch

TeleTrader 11/30/2016 Valeant fails to sell Salix, sources reveal